Regulatory Filings • Jul 30, 2019
Regulatory Filings
Open in ViewerOpens in native device viewer
Photocure to present at European Biotech Investor Day 2019 in New York
Oslo, Norway, August 1, 2019 - Photocure ASA (OSE: PHO) management is conducting
investor meetings in New York (US) on August 1, 2019, in connection with the
European Biotech Investor Day, organized by Solebury Trout and sponsored by
Goodwin LLC, Deutsche Bank, H.C. Wainwright and Nasdaq.
The presentation will be posted on www.photocure.com when held on August 1,
Company contact:
Erik Dahl, Chief Financial Officer
Tel: +47 450 55 000
Email: [email protected]
About the European Biotech Investor Day
The European Biotech Investor Day in NYC, features privately-held and EU-listed
biotechnology companies representing the "Next Wave of Opportunities" emerging
from Europe.
About Photocure ASA
Photocure, The Bladder Cancer Company, delivers transformative solutions to
improve the lives of bladder cancer patients. Our unique technology, making
cancer cells glow bright pink, has led to better health outcomes for patients
worldwide. Photocure is headquartered in Oslo, Norway and listed on the Oslo
Stock Exchange (OSE: PHO). For more information, please visit us at
www.photocure.com, www.hexvix.com, www.cysview.com.
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.